Skip to main content
Nanobiotix logo

Nanobiotix — Investor Relations & Filings

Ticker · NANO ISIN · FR0011341205 LEI · 969500667RSYIH8YL895 PA Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2016-05-13 Earnings Release
Country FR France
Listing PA NANO

About Nanobiotix

https://www.nanobiotix.com/

Nanobiotix is a late-stage clinical biotechnology company pioneering a physics-based approach to cancer treatment through the development of nanotherapeutics. Its lead product candidate, NBTXR3, is a potential first-in-class radioenhancer designed to be injected directly into a tumor. When activated by radiotherapy, NBTXR3 amplifies the radiation dose within the tumor, aiming to destroy cancer cells more effectively without increasing exposure to surrounding healthy tissues. This process is also intended to prime an immune response to target metastatic tumors. The company is developing NBTXR3 for broad application across various solid tumors, with an initial focus on head, neck, and lung cancers through a global licensing agreement with Janssen Pharmaceutica NV.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Communiqué sur comptes, résultats, chiffres d’affaires
Earnings Release Classification · 98% confidence The document is titled "Chiffre d'affaires du premier trimestre 2016" (First Quarter 2016 Revenue) and presents key financial figures (Compte de résultat) for the first quarter, comparing them to the previous year's first quarter (T1 2016 vs T1 2015). It discusses revenue recognition, clinical trial updates (FDA IND acceptance), financing activities (private placement), and announces the date for the next financial communication (Q2 2016 revenue). This structure—presenting key financial results for a period shorter than a year—is characteristic of an Interim/Quarterly Report. Although it contains some operational updates, the core focus is the quarterly financial performance summary. It is not a full Annual Report (10-K), a simple Earnings Release (ER) which is usually just highlights, or a Management Discussion & Analysis (MDA) which is more narrative. It is a comprehensive quarterly financial report, fitting the 'Interim / Quarterly Report' definition (IR). The document also mentions an upcoming AGM, but the primary content is the Q1 financial results. Q1 2016
2016-05-13 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital) and explicitly references Article 223-16 of the AMF (Autorité des Marchés Financiers) General Regulation. It provides a table detailing the total number of shares and voting rights as of April 30, 2016. This type of mandatory periodic disclosure regarding the total share capital and voting rights structure is a specific regulatory filing requirement in France, often related to changes in major shareholdings or capital structure transparency. While it touches upon capital structure (SHA) or major shareholding (MRQ), the specific format and reference to the monthly voting rights disclosure strongly align with notifications concerning significant ownership thresholds or capital structure updates that are frequently categorized under general regulatory announcements or specific share/capital change notifications. Given the options, this is a mandatory regulatory disclosure about the capital structure and voting rights, which is a specific type of filing. It is not a full report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). It is most closely related to changes in share capital or major holdings, but since it is a standardized monthly disclosure of the total count, it fits best under a general regulatory filing category if a more specific one isn't available. However, since it explicitly details the total number of shares and voting rights, it is a direct notification about the capital structure. Comparing the definitions, 'SHA' (Share Issue/Capital Change) is close, but this is a routine monthly count, not necessarily an 'issue' or 'change' announcement. 'MRQ' (Major Shareholding Notification) is also close, but this is the total count, not a notification of a specific shareholder crossing a threshold. Given the mandatory nature and the specific content (total voting rights/shares), it falls under a general regulatory filing category. Since the content is a direct regulatory disclosure about the capital base, and not a general announcement of a report (RPA), 'RNS' (Regulatory Filings) is the most appropriate fallback for this specific, non-standardized report type among the choices, although it is a very specific type of regulatory filing.
2016-05-09 French
Rapport financier annuel
Annual Report Classification · 100% confidence The document is titled 'RAPPORT FINANCIER ANNUEL EXERCICE 2015' (Annual Financial Report for the 2015 fiscal year). It contains a comprehensive summary, management report (Rapport de gestion du directoire), consolidated financial statements prepared under IFRS, and audit reports from the statutory auditors. It is a full-year comprehensive report, not an announcement or a summary, fitting the definition of an Annual Report (10-K). FY 2015
2016-04-30 French
Communiqués de mise à disposition de documents / Modalités de mise à disposition du rapport financier annuel
Report Publication Announcement Classification · 99% confidence The document is very short (3142 characters) and its primary purpose, as indicated by the title "Mise à disposition du Rapport Financier Annuel 2015" (Making available of the 2015 Annual Financial Report) and the body text, is to inform shareholders that the Annual Financial Report has been filed with the AMF and is available for consultation on the company website. This fits the definition of a Report Publication Announcement (RPA), which announces the release or availability of a report, rather than being the comprehensive report itself (like a 10-K or AR).
2016-04-30 French
Communicated under the obligation to provide permanent information / Communication relating to accounts, results, and turnover
Earnings Release Classification · 96% confidence The document is explicitly titled "Nanobiotix: 2015 Annual Results" and provides audited consolidated results for the fiscal year ended December 31, 2015, including a detailed Income Statement table comparing 2015 and 2014 figures, and a Financial Review section. This content structure is characteristic of a comprehensive annual financial report. Although it is presented as a press release dated April 29, 2016, the core content is the full annual financial disclosure, which aligns best with the 'Annual Report' category (10-K), even if this specific filing might be an international equivalent or a press release accompanying the formal 10-K filing. Given the depth of the audited results and the focus on the full fiscal year, 10-K is the most appropriate classification among the provided options, distinguishing it from a brief Earnings Release (ER) or an Interim Report (IR). The document length (13,643 chars) also supports it being a comprehensive report rather than a short announcement. FY 2015
2016-04-29 English
Communiqués au titre de l'obligation d'information permanente / Communiqué sur comptes, résultats, chiffres d’affaires
Earnings Release Classification · 97% confidence The document is titled "Nanobiotix : RÉSULTATS ANNUELS 2015" and provides a detailed summary of the company's financial performance for the fiscal year 2015, including a consolidated income statement table, commentary on revenue, operating expenses, net result, and significant clinical/corporate milestones achieved during 2015 and outlook for 2016. The text explicitly states 'résultats annuels consolidés audités pour l'exercice 2015' (audited consolidated annual results for the 2015 fiscal year). Although it mentions the results were 'not audited' in the final disclaimer, the primary content structure, focus on full-year financials, and the explicit mention of 'Annual Results' strongly align with the content expected in an Annual Report (10-K) or a very detailed Earnings Release/Interim Report. Given the comprehensive nature, including detailed financial tables and management discussion, it functions as the primary annual financial disclosure. Since it is a detailed report covering the full year, it fits the 'Annual Report' category (10-K) better than a simple Earnings Release (ER) or Interim Report (IR), even if it might be a press release version of the 10-K filing or a French equivalent. The length (over 16k characters) also supports it being a comprehensive report rather than just an announcement (RPA). FY 2015
2016-04-29 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.